These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26844555)
1. Biotechnological Fluorescent Ligands of the Bradykinin B1 Receptor: Protein Ligands for a Peptide Receptor. Charest-Morin X; Marceau F PLoS One; 2016; 11(2):e0148246. PubMed ID: 26844555 [TBL] [Abstract][Full Text] [Related]
2. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor. Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582 [TBL] [Abstract][Full Text] [Related]
3. Bifunctional ligands of the bradykinin B Marceau F; Bawolak MT; Fortin JP; Morissette G; Roy C; Bachelard H; Gera L; Charest-Morin X Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875 [TBL] [Abstract][Full Text] [Related]
4. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
5. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Butt SK; Dawson LG; Hall JM Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687 [TBL] [Abstract][Full Text] [Related]
6. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors. Meini S; Lecci A; Maggi CA Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268 [TBL] [Abstract][Full Text] [Related]
7. Lack of direct interaction between enalaprilat and the kinin B1 receptors. Morissette G; Couture JP; Désormeaux A; Adam A; Marceau F Peptides; 2008 Apr; 29(4):606-12. PubMed ID: 18201802 [TBL] [Abstract][Full Text] [Related]
8. Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. Talbot S; Théberge-Turmel P; Liazoghli D; Sénécal J; Gaudreau P; Couture R J Neuroinflammation; 2009 Mar; 6():11. PubMed ID: 19323833 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin-bradykinin receptor (B1R) signalling is involved in the blood-brain barrier disruption in moyamoya disease. Wang H; Sun W; Li F; Jiang P; Wang L; Zhou N; Feng L J Cell Mol Med; 2023 Dec; 27(24):4069-4079. PubMed ID: 37818853 [TBL] [Abstract][Full Text] [Related]
11. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
12. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related]
13. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. Drapeau G; deBlois D; Marceau F J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280 [TBL] [Abstract][Full Text] [Related]
14. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs. Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755 [TBL] [Abstract][Full Text] [Related]
15. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. Larrivée JF; Bachvarov DR; Houle F; Landry J; Huot J; Marceau F J Immunol; 1998 Feb; 160(3):1419-26. PubMed ID: 9570562 [TBL] [Abstract][Full Text] [Related]
16. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189 [TBL] [Abstract][Full Text] [Related]
18. Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors. Morissette G; Houle S; Gera L; Stewart JM; Marceau F Br J Pharmacol; 2007 Feb; 150(3):369-79. PubMed ID: 17179948 [TBL] [Abstract][Full Text] [Related]
19. The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Cruwys SC; Garrett NE; Perkins MN; Blake DR; Kidd BL Br J Pharmacol; 1994 Nov; 113(3):940-4. PubMed ID: 7858889 [TBL] [Abstract][Full Text] [Related]
20. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958. Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]